003017.SZ
大洋生物
SZSE · Basic Materials · C 制造业 · CN
CNY 22.48
+0.27%Aug 24, 2026, 10:50 UTC
Dayang Biology proposed a cash dividend of 3 yuan per 10 shares (tax inclusive) based on 100.8 million shares, with no bonus shares and no capital reserve conversion.
Source:Aug 24, 2026, 10:50 UTC
Dayang Biology announced its 2026 first-half results: revenue of 559 million yuan, up 11.93% year-on-year; net profit attributable to shareholders of 57.4693 million yuan, up 13.79%; non-GAAP net profit of 53.7404 million yuan, up 14.93%.
Source:Aug 8, 2026, 10:19 UTC
Next week, 29 A-share stocks will face share unlockings with a total market value of 27.2 billion yuan, of which Lujiazui has the largest unlocking value at 7.11 billion yuan.
Source: